Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 330.85 INR 0.33% Market Closed
Market Cap: 30.5B INR
Have any thoughts about
Indoco Remedies Ltd?
Write Note

Indoco Remedies Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indoco Remedies Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Current Portion of Long-Term Debt
â‚ą473m
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Current Portion of Long-Term Debt
â‚ą41.2B
CAGR 3-Years
256%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Current Portion of Long-Term Debt
â‚ą2.4B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Current Portion of Long-Term Debt
â‚ą22B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Current Portion of Long-Term Debt
â‚ą16.5B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Current Portion of Long-Term Debt
â‚ą231.2m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
30.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
409.51 INR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
473m INR

Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Current Portion of Long-Term Debt amounts to 473m INR.

What is Indoco Remedies Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-3%

Over the last year, the Current Portion of Long-Term Debt growth was -14%. The average annual Current Portion of Long-Term Debt growth rates for Indoco Remedies Ltd have been 1% over the past three years , -3% over the past five years .

Back to Top